Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amgen Q3 Adj. EPS $5.64 Beats $5.01 Estimate, Sales $9.557B Beat $8.967B Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:02pm
Amgen (NASDAQ:AMGN) reported quarterly earnings of $5.64 per share which beat the analyst consensus estimate of $5.01 by 12.49 percent. This is a 1.08 percent increase over earnings of $5.58 per share from the same period last year. The company reported quarterly sales of $9.557 billion which beat the analyst consensus estimate of $8.967 billion by 6.58 percent. This is a 12.40 percent increase over sales of $8.503 billion the same period last year.

Posted In: AMGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist